In today’s CEO Daily: Diane Brady talks to AstraZeneca CEO Pascal Soriot. The big story: Trump punishes the WSJ for its Epstein scoop. The markets: Low drama. Analyst notes from Deutsche Bank on ...
A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement about lowering U.S. drug prices, at the White House in Washington, ...
Hosted on MSN
AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO
AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...
AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm's commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Stream Los Angeles News ...
Hosted on MSN
Britain losing race to make new drugs: AstraZeneca boss blasts UK for deterring investment
The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...
The “most favored nation” (MFN) drug pricing deal AstraZeneca recently signed with the Trump administration won’t affect the British pharma’s revenue target, CEO Pascal Soriot said. “We can absorb the ...
Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. CEO Pascal Soriot is ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President ...
LONDON, Sept 10 (Reuters) - AstraZeneca's (AZN.L), opens new tab chief executive Pascal Soriot said on Thursday that it should know before the end of the year whether its experimental vaccine would ...
AstraZeneca CEO Pascal Soriot on Tuesday reiterated the pharmaceutical firm's commitment to the U.S. market amid reports that he is considering shifting its listing stateside. Soriot said the ...
LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices for millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback